ACADIA Pharmaceuticals Earning Date (ACAD)

USA |NASDAQ |USD

ACAD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 22, 2022 Dec 2021 $-0.24 $-0.09 $-0.42
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 22, 2022 Dec 2021 $135.38M $131.61M $121.01M

Acadia Pharmaceuticals's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 2021.

ACAD Earnings Date & History Chart

ACAD Earnings & Revenue Forecast

ACAD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 6 $-0.25 $-0.40 $-0.02
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 21 $-0.90 $-1.60 $0.22

ACAD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 2 / 0 $-0.23 $-0.27 $-0.25
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 3 $-0.90 $-0.94 $-0.92

ACAD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 5 $128.36M $120.00M $137.60M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 21 $569.87M $501.71M $675.00M

ACAD Earnings Date & Revenue History

ACAD Earnings History

|
Show More
Show More

ACAD Revenue History

|
Show More
Show More

Acadia Pharmaceuticals Next Earnings Date & Report

ACAD Next Earnings Date & Report Preview: Dec 2021 (FQ)

ACAD's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 20 analysts, the average EPS estimation for Acadia Pharmaceuticals's next quarterly earnings is $-0.24, with a low EPS estimation of $-0.37, and a high estimation of $-0.07.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 1 downward. The EPS 1 month trend is $-0.24, the last 2 month trend is $-0.26, and the 3 month trend is $-0.26.

Based on 16 analysts, the average revenue estimation is $135.38M, with a low revenue estimation of $128.20M, and a high estimation of $142.71M.

Acadia Pharmaceuticals Previous Earnings Dates & Reports

ACAD Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Acadia Pharmaceuticals's previous earnings date was Nov 8, 2021 for its fiscal quarter ended Sep 30, 2021.

ACAD's earnings per share (EPS) was $-0.09, beating the consensus analysts forecast of $-0.26 by 65.06%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -66.67%, and higher than the same period a year before (Sep 2020) by -83.33%.

Revenues were $131.61M, better than the forecast of $127.75M by 3.02%, up by 14.23% from the previous quarter , and up by 9.15% from the same period last year.

The company reported a net income of $-14.46M.

Free cash flow for the quarter was $-17.06M , compared to $-25.37M last quarter and $-24.51M a year before.

ACAD ended the quarter with $65.83M in total debt, a decrease of -1.24% compared to the previous quarter, and an increase of 33.79% compared to the same quarter a year before.

ACAD Previous Earnings Date & Report Recap: Dec 2020 (FY)

Acadia Pharmaceuticals's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.

ACAD's earnings per share (EPS) was $-1.80, beating the consensus analysts forecast of $-1.84 by -2.17% , and lower than the previous year's EPS (Dec 2019) by 12.50%.

Revenues were $441.75M, worse than the forecast of $444.12M by -0.53%, and up by 30.28% from previous year's revenue.

The company reported a net income of $-281.58M.

Acadia Pharmaceuticals reported a free cash flow of $-143.75M for its fiscal year, compared to $-152.26M a year ago.

The company ended the fiscal year with $49.55M in total debt, an increase of 405.84% compared to the previous year.